Evaluating exercise capacity in patients with pulmonary hypertension

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates patients diagnosed with pulmonary hypertension, including pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, using cardiopulmonary exercise testing. The assessments are conducted before and after treatment with medical therapy or balloon pulmonary angioplasty. The goal is to determine the effectiveness of these interventions on patients' exercise capacity and overall health outcomes. This observational study aims to provide insights into the management of pulmonary hypertension.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* pulmonary arterial hypertension;( WHO1)
* chronic thromboembolic pulmonary hypertension;
* pulmonary arterial hypertension due to other cause;

Exclusion Criteria:

* massive hemoptysis;
* unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders;
* recent recurrent syncope;
* pulmonary hypertension due to hypoxia;
* pulmonary hypertension due to left heart diseases.

Where it's running

• center of pulmonary vascular disease, Fuwai hospital
  Beijing, China Recruiting

Study contacts

• Study coordinator: Zhihong Liu, Doctor
• Email: zhihongliufuwai@163.com
• Phone: 8601088396590

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Rutgers Genetics of Pulmonary Hypertension

  This online project will try to see if genetic differences affect the risk of pulmonary hypertension in U.S. adults, and anyone 18 or older can join whether or not they have PH.

  Recruiting Rutgers, The State University of New Jersey · Piscataway, New Jersey · NCT07217522

• Registry and biorepository for pulmonary hypertension patients

  This study is setting up a collection of health information and blood samples from people with pulmonary hypertension to help researchers learn more about the disease and improve treatments.

  Recruiting University of Kansas Medical Center · Kansas City, Kansas · NCT04808596

• Registry for patients with pulmonary hypertension

  This study collects information from people with pulmonary hypertension to see how they are diagnosed and treated, and to find ways to improve their care.

  Recruiting at 51 sites Pulmonary Hypertension Association, Inc. · Phoenix, Arizona and 51 other locations · NCT04071327

• Levosimendan to see if it helps the heart after PEA in CTEPH

  This small randomized trial tests whether giving levosimendan around surgery helps reduce pulmonary artery pressure and support right heart function after pulmonary endarterectomy for CTEPH.

  Recruiting Meshalkin Research Institute of Pathology of Circulation · Novosibirsk · NCT07914933

• Pulmonary Embolism Registry from Emergency Care to Long-Term Follow-Up

  This registry follows adults with acute pulmonary embolism to see how care is given in the real world and what happens over time.

  Recruiting at 16 sites Azienda Ospedaliero-Universitaria Careggi · Bagno a Ripoli, Tuscany and 15 other locations · NCT07855679

• Early treatment with inhaled treprostinil for exercise-induced pulmonary hypertension in ILD or CTD

  This study tests whether inhaled treprostinil added to standard care can improve exercise-related lung blood flow and function in adults with ILD or CTD who develop pulmonary hypertension during exercise.

  Recruiting at 2 sites Early Phase 1 Valley Health System · Paramus, New Jersey and 1 other locations · NCT07837830

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.